The last two decades have provided clear evidence for the tight and ca
sual relation existing between arrhythmic mortality and the autonomic
nervous system, particularly with imbalances characterized by decrease
s in vagal and/or increases in sympathetic activity. A series of compe
lling experimental results has represented the driving force for the c
linical evaluation of the potential prognostic value of baroreflex sen
sitivity (BRS), a measure that can provide information on the capabili
ty to augment vagal activity. This article reviews the methodology mor
e commonly used to quantify the clinical evaluation of this parameter,
and then focuses on the key clinical studies highlighting those perfo
rmed in postmyocardial infarction patients. Among them the most inform
ative is ATRAMI, a multicenter prospective study involving almost 1300
patients. The main conclusion is that both heart rate variability and
BRS are strong and independent risk factors for post-infarction morta
lity, thus demonstrating the clinical usefulness of autonomic markers.